Get your family ACTIVE this summer
Get in shape for summer
Monitor your family remotely
Plan your family trips at the right time
Managing COPD from home
  • Welcome to the new version 3.0 of the Activ8rlives Data website, which now hosts an enhanced Dashboard and many new features that allow you to be more in control of your Health Data and in control of people that you may act as carers. You have the choice of using either the ‘Simple’, ‘Advanced’ or ‘Expert’ settings by selecting the buttons in the top right-hand corner to switch between increasingly complex dashboard layouts. The choice you make is saved for the next time you Login to your Activ8rlives account using the same email and password that you use on one of Activ8rlives’ Apps. The Simple display for the Dashboard shows your latest reading for Steps and Weight. Your latest Weight reading and the Height you entered when registering is used to calculate your BMI (Body Mass Index). Your BMR (Basal Metabolic Rate) is how much energy a typical person of your age, height, weight and gender might burn in a day. Note each score is indicated in Green, Amber or Red (Traffic Light system) that indicates whether this parameter is within normal range for your targets, weight, height, age, gender etc. Those in Blue do not have a normal range or target associated with them.
  • Aseptika Limited is one of ten European SME’s to be selected for inclusion in the 2016 Medical Device SME Hotlist, published by the Council of European BioRegions asbl (CEBR). Aseptika are supporting patients to manage long-term respiratory conditions more effectively, which is a high priority for the NHS. The aim is for patients to become experts in their own health and safely manage their condition in the comfort of their own home, with fewer unplanned hospital admissions and a higher overall quality of life.   As a network of 40 life science clusters across Europe, CEBR is dedicated to supporting cluster and SME development. CEBR has developed an online SME Medical Device Directory with its members, which showcases SMEs directly involved in the development of innovative medical devices. The directory, launched in 2016, creates a critical mass of novel technologies from Europe’s SMEs, enabling partners and investors across the World to find the right companies for development.   In spring 2016, CEBR also launched a Hot List process, where cluster managers nominated the medical device SME from within their community that has made the greatest progress since directory launch in June 2016.    March 18 sees the publication of this hotlist, with 10 SMEs nominated by 10 different clusters. The Hotlist SMEs will be showcased in a dedicated webinar on April 11, 2016 at 11:00 CET.  Click here to attend the webinar free of charge.   ENDS       About CEBR Medical Device Directory and Hotlist:  The Council of European BioRegions asbl brings together over 60 SMEs from 11 clusters across Europe in a rapidly growing online directory dedicated to the development of medical devices.  Launched in June 2016, the focus of the directory is on SMEs as developers of their own components or complete devices and has the aim to create a centralised hub for investors and partners to find the right SMEs for global development and distribution.  The 2016 Hotlist celebrates 10 SMEs that have made substantial scientific or business progress since the directory launch in 2016.  It was generated through nominations from the clusters participating in the directory.  The Directory and Hotlist is sponsored in 2016 by Teijin Pharma Ltd. CEBR useful links: ·        Medical Device Directory: http://www.lifescience-cluster-innovations.space/european-medical-device-sme-directory/ ·        Medical Device SME Hotlist: http://www.lifescience-cluster-innovations.space/european-medical-device-sme-directory/hot-list/ ·        April 11 webinar and registration: http://www.lifescience-cluster-innovations.space/event/sme-medical-device-hotlist-showcase-webinar/  
  • Aseptika is one of just five companies to win a place on the IoTUK Boost mentoring programme, awarded “Highly Commended in Health and Social Care category”. The Company now gains expert mentoring and support in the onward development of the BuddyWOTCHTM medical wearable, designed for those with long-term cardiovascular and respiratory conditions. Aseptika will receive further support via Cambridge Wireless, SETsquared and IoTUK through membership of their associated networks, physical and virtual showcase opportunities, additional mentoring and support from our expert partner organisations 4YFN, Alloy, Arkessa, Breed Reply, DHACA, EAHSN, Iotic Labs, MediaTek Labs and Tradefair. “The IoTUK Boost prize winners are commended for the clarity of their business proposition, the simplicity of their user design, the sophistication of their health and social Care technology”, said Bob Driver, CEO of CW.   Caption: Aseptika Limited (Activ8rlives) awarded the Highly Commended in Health and Social Care category of the IoTUK Boost.    Read the full Press Release from Cambridge Wireless here.    IoTUK Boost unveils next big things in health and social care tech  Five prizewinners announced in programme to connect IoT start-ups with problem owners across South England. Cambridge, 29 February, 2016 – In November of last year CW (Cambridge Wireless) were selected as local partners of the IoTUK Boost programme, which aims to convene and amplify the UK’s IoT industry to help business and economic growth. Covering the South of South of England and focusing on health and social care technology, CW together with SETsquared, RTACS, and 5GIC at the University of Surrey ran a competition to select SMEs for rapid incubation workshops in Bristol and Guildford. During these workshops successful SMEs received mentorship from and pitched to representatives of prominent healthcare networks, consultancies and IoT leading companies. From the successful SMEs five prizewinners have now been selected to receive further incubation support from CW, SETsquared and IoTUK through membership of their associated networks, physical and virtual showcase opportunities, and additional mentoring and support from our expert partner organisations 4YFN, Alloy, Arkessa, Breed Reply, EAHSN, Iotic Labs, Tradefair, and MediaTek Labs.   ‘The five prizewinners are commended for the clarity of their business proposition, the simplicity of their user design, the sophisticated of their health and social care technology, as well as the strong improvement throughout they showed over the course of the programme’ said Bob Driver, CEO of CW. ‘Whether they were prizewinners of not, all the SMEs who were selected for the programme have benefited from making new contacts with fellow entrepreneurs, advisors and even potential business partners. Wherever necessary CW will be on hand to help them follow up on these connections.’   Follow this link to see the Five Prizewinners.      
  • NHS England has announced the five centres that have been awarded the status of Innovation Test Beds in which new approaches to healthcare provision will be assessed and adopted and two centres for the adoption of the Internet of Things (IoT) in healthcare.  Aseptika is pleased to announce that it is one of the innovators partnering with the Test Bed programme in Sheffield for the trial and integration of its Activ8rlives solution for patients with respiratory disease into the new pathways of care. Test Beds are a new collaborations between the NHS and innovators like Aseptika, which aim to harness technology to address some of the most complex and challenging issues facing patients and the health service.   Successful innovations will then be available for other parts of the NHS to adopt and adapt to the particular needs of their local populations. The ‘Perfect Patient Pathway’, as the Sheffield City region Test Bed will be known, aims to create the ‘perfect patient pathway’ to bring substantial benefits for patients suffering from long term health conditions, such as diabetes, mental health problems, respiratory diseases, hypertension and other chronic conditions.    Ends     About Sheffield Teaching Hospitals NHS Foundation Trust  View the Media Release about Sheffield’s Perfect Patient Pathway test bed by following this link.   About Aseptika Limited (Activ8rlives):  Aseptika Limited is a healthcare company developing and marketing an integrated suite of self-monitoring devices and services under the Activ8rlives brand. We are developing integrated systems which can be used by consumers and their healthcare service providers to better self-manage long-term health conditions (LTHC) through self-monitoring. The Company’s goal is to provide everyone with tools (and the understanding of how to apply them) so that most of us can keep healthy and well for most of the time. Self-management through self-monitoring is the motivation driving what we do. Activ8rlives is unusual in that we are device agnostic, incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs) with a focus on respiratory disease. All data is held together and can be cross analysed in the Cloud to provide forecasts and learning for the user and clinician. The Company gained a patent in 2013 protecting the invention of a test for biomarkers of Pseudomonas aeruginosa (PA) in the sputum of patients, which can be used to detect the on-set of an exacerbation and profile the efficacy of antibiotic treatment for each patient. Aseptika won first place in a competition earlier in 2014 to reward the most “Promising eHealth EU SME”eHealth solution 2014developed by an early-stage European SME. The 2014 Competition was organized by TICBioMed and had the endorsement of the Health and Wellbeing Unit of DG CONNECT of the European Commission. Aseptika was a shortlisted finalist for the Cambridge News Top Innovations 2014 and won the  AXA PPP Health Tech & You Awards. Winner of the Discovery Start-up 2014 Competition run by Cambridge Wireless and Winner of the Hunts Post Huntingdonshire Business Innovation Awards 2014. Named on Global Digital Health 100 2014, reflecting the importance of mobile and digital solutions. Wearable Technology Awards 2015 shortlisted Aseptika in three categories: Best Medical Device (placed third), Best Innovation and Overall Wearable Winner.  Aseptika was granted a patent in the United States and New Zealand protecting its invention for a test for respiratory infections early in 2015.  Aseptika was short-listed as one of twenty semi-finalists for the Cisco British Innovation Gateway (BIG) Awards and was also awarded winner of the Innovation Award for BuddyWOTCH at the Hunts Post Business Awards for 2015.  The Global Digital Health 100 List for 2015 has been named Aseptika Ltd (Activ8rlives) in the list of 100 companies for the second year in a row.  For more information on Aseptika Ltd, Activ8rlives and products, please visit: www.Activ8rlives.com   Activ8rlives, Activ8rlives.com, BuddyWOTCH and EyKos are trademarks of Aseptika Ltd.      For press information, please contact:      Jessica Auton, Marketing Director,   jessica.auton@aseptika.com   Direct +44 (0)1480 352 821  Mobile +44 (0)7455 922 122    
  • The Global Digital Health 100 List for 2015 was announced today in the Journal of mHealth and Aseptika Limited (Activ8rlives) has been named in the list of 100 companies for the second year in a row. The Global Digital Health 100 represents 6 months of analysis by the editorial and advisory team at The Journal of mHealth, who consider the offerings and innovations from companies across the digital health ecosystem, prior to selecting the final 100. In compiling this year’s 100 companies list are achieved by a combination of nominations and industry research to identify the most innovative and effective global companies operating in the mobile, digital and connected healthcare industries. The criteria for selection for inclusion on the 100 list includes: disruptive impact; proof of concept; technology innovation; social value; effectiveness; execution of strategy; and industry integration. Organisers of the Global Digital Health 100 List for 2015 commented about the companies selected for the 100 List: “The diversity of this year’s list stands out straight away. With innovations targeting just about every corner of healthcare the honouree companies offer technologies across a range of categories including, clinical solutions, wearable technologies, healthcare applications, medical devices, and data analytics. These are all solutions and services that are transforming, or have the potential to transform, and disrupt the way in which healthcare is delivered. Reflecting the growing prominence of mobile, digital and connected solutions in the healthcare sector, the Global Digital Health 100 acknowledges the significant work being carried out by organisations from around the globe. This year’s list similarly recognises an industry that is showing the signs of early maturity. As we progress from what some would describe as digital health 1.0 to digital health 2.0, 3.0 and beyond, then we can expect the role that these organisations play in everyday healthcare delivery to become greater and more widespread.” Kevin A Auton, managing director of Aseptika Limited commented on the award by saying: “This award tops off an extremely busy and pivotal year for the company and also corresponds with our first NHS England contract, reflecting the adoption of new care models in line with Simon Steven’s Five Year Forward View. It’s an honour and unexpected early Christmas present to our small and dedicated team, which we greatly appreciate in helping us to bring self-care to consumers and healthcare providers alike.”   
Self-monitoring

Self-monitoring

Our strategy is to develop expert systems which can be used by consumers and their healthcare service providers to better self-manage long-term conditions through self-monitoring at home

Read More
Biomarker Tests

Biomarker Tests

A natural extension of this philosophy is the Company's development of a home-based test to predict flare-ups in chest infections (in people of all ages) who have long-term respiratory conditions, to reduce hospital admissions and improve healthcare

Read More
Always Connected

Always Connected

Our strategy is to enable self-management through self-monitoring without needing PCs, Smartphones, Tablets and the dedicated medical touch screen devices that are often deployed in telemedicine.

Read More
Clinical Trials

Clinical Trials

Aseptika is developing a home-based rapid and quantitative biomarker test for a common bacterial lung infection and 3rd generation devices for use with long-term lung disease sufferers. Clinical trials will be undertaken with NHS partners to validate their clinical effectiveness.

Read More
Corporate Wellness

Corporate Wellness

By supporting and providing your employees with the right tools to self-monitor their health and by encouraging and rewarding them, your employees can benefit from a healthier life and be more productive as a result

Read More
Healthcare Collaborators

Healthcare Collaborators

We work with a highly talented team of collaborators, brilliant technologists, passionate clinicians, mentors/supporters in the NHS and of course, our customers and volunteers whom we adore

Read More

Our Devices

BuddyBand2 Waterproof Bluetooth Activity & Sleep Tracker

The Activ8rlives BuddyBand2 is waterproof (to 2m for 30 minutes) activity and sleep tracker, with up-gradable firmware, built-in notifications for calls, texts, social media when paired with a Smartphone, sleep tracking, inactivity alert, and with data uploaded by Bluetooth Smart (4.0).

BuddyBand2

NEW Buddy Step Counter

The NEW Activ8rlives Buddy Step Counter is a simple and popular electronic wearable device, which measures your activity and energy expenditure throughout the day. Data can be downloaded directly to your FREE Activ8rlives online account by mini USB via your PC/Mac.

New Buddy Step Counter

Body Analyser Bluetooth Smart Scales

Track your weight and body composition with our custom body analyser, beautifully finished in black. Weight, fat, water, muscle composition, visceral fat levels, bone % and BMI. Uploads data directly to our Free Smartphone App.

Body Analyser

Blood Pressure Bluetooth Monitor

The Activ8rlives Blood Pressure Bluetooth 4.0 monitor is an easy-to-use device that can measure your blood pressure — especially useful if you suffer from previously diagnosed conditions which result in high or low blood pressure. The monitor also measures the interval between your pulse waves and determines the standard deviation. If the standard deviation is above a certain level, it gives a warning of an irregular heart beat.

Blood Pressure Monitor

Pulse Oximeter Bluetooth

The Activ8rlives Pulse Oximeter Bluetooth 4.0 is a non-invasive method which allows you to monitor aspects of your pulmonary and cardiovascular functions — especially if you have Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) and need to track you oxygen saturation levels and pulse rate.

Pulse Oximeter

POGO Bluetooth USB Hub

Allows data from USB devices to upload to your Smartphone by Bluetooth 4.0, even if your Smartphone or Tablet do not have Bluetooth capability. Inserted into earphone socket of Smartphones and Tablets.

POGO Bluetooth USB Hub

Contactless Thermometer Bluetooth

The Activ8rlives Contactless Thermometer Bluetooth 4.0 is an easy-to-use device that can measure your body’s temperature. It sends information to your private personal Activ8rlives account via your Bluetooth 4.0 enabled Smartphone or Tablet so that you can see your precise temperature without contact or disposables and to help you keep track of your health and wellbeing and that of your family.

Contactless Thermometer

Sign up to our Newsletter

Offering a simple way to Activ8rlives

Self-monitoring solutions for health and wellness, improve health and maintain wellness for the whole family, group or company.

Register now and start your
FREE Wellness Check

Download the App

The Activ8rlives app is available on multiple platforms
iOS AppAndroid AppAndroid App Windows PC (XP, Vista, 7 and 8)MAC (Leopard, Snow leopard, Lion, Yosemite and El Capitan)